SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-033797
Filing Date
2024-02-13
Accepted
2024-02-13 16:29:52
Documents
1
Group Members
APEIRON PRESIGHT CAPITAL FUND II, L.P.CHRISTIAN ANGERMAYERFABIAN HANSENPRESIGHT CAPITAL MANAGEMENT I, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d787948dsc13ga.htm SC 13G/A 101226
  Complete submission text file 0001193125-24-033797.txt   103075
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93405 | Film No.: 24626498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Filed by) CIK: 0001845711 (see all company filings)

IRS No.: 000000000 | State of Incorp.: O1 | Fiscal Year End: 1231
Type: SC 13G/A